
Sign up to save your podcasts
Or


Discussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.
By The Lancet NeurologyDiscussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.

43,643 Listeners

294 Listeners

532 Listeners

51 Listeners

112,376 Listeners

88 Listeners

514 Listeners

181 Listeners

58 Listeners

79 Listeners

0 Listeners